RAPID DISPATCH
24/H dispatch
5 in stock
XELA REDERM 2,2% is a highly concentrated injectable skin booster, formulated with non-crosslinked hyaluronic acid (22 mg/ml) and succinic acid, indicated for the treatment of mature skin and the correction of the most advanced signs of skin ageing. Thanks to redermalisation technology, the product acts by improving deep hydration, firmness and overall skin quality.
The high concentration of hyaluronic acid helps restore skin trophism and improve tissue elasticity, while succinic acid supports cell metabolism and helps combat oxidative stress. XELA REDERM 2,2% is particularly indicated in the presence of skin laxity, loss of tone and obvious signs of photo-ageing, without creating artificial volume.
USE MEDICAL STRICT. Medical device. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
XELA REDERM 2.2% 2ML is a solution:
- With physiological and isotonic formula, highly biocompatible.
- Intensive redermalising action, indicated for mature skin or skin with marked loss of tone.
- Supports cell metabolism and contributes to improved firmness, elasticity and skin quality.
- HYALUAL
- NAME: XELA REDERM 2.2% 2ML
- COMPOSITION: High molecular weight hyaluronic acid 2.2%, succinic acid 1.6%.
- PRESENTATION: 1 x 2 ml.
- NEEDLES: 2 x 30G.
- INDICATIONS: Lifting. Improvement in skin quality due to dermis compaction. Reduction of wrinkle depth. Definition of the lip contour. Restoration of the water balance in the dermis.
- INJECTION DEPTH: Superficial dermis - medium.
- DURATION: A cycle of 3-5 sessions with 1-2 week intervals between sessions is recommended, varying according to the maturity of the skin.
- USE: Strict medical use.
- Syringe: 1 x 2 ml.
- Needles: 2 x 30G.
Face, cheeks, zygomatic area, neck, décolleté, hands.
High molecular weight hyaluronic acid 2.2%, succinic acid 1.6%.
- The product must only be used by qualified medical personnel experienced in aesthetic medicine.
- Carry out a thorough patient history before treatment, assessing allergies, current therapies and clinical conditions.
- Use strict aseptic techniques and sterile disposable material.
- Avoid administration in areas recently treated with other injectable devices, unless medically assessed.
- Do not mix the product with other substances or drugs not expressly indicated.
- Inform the patient of the possible occurrence of transient local reactions (redness, oedema, slight pain or a feeling of tension).
- After treatment, avoid exposure to intense heat, UV radiation, vigorous massage or intense physical activity for the period indicated by the doctor.
XELA REDERM 2,2% 2ML is contraindicated in the following cases:
- Known hypersensitivity or allergy to hyaluronic acid, succinic acid or any of the components of the product.
- Presence of active skin infections, inflammation, dermatitis or lesions in the area to be treated.
- Active autoimmune diseases or uncontrolled conditions of immunodepression.
- Pregnancy and lactation.
- Previous significant adverse reactions to hyaluronic acid-based injectable treatments.
- Clotting disorders or unstabilised anticoagulant therapy.
- Patients below the age stipulated in the device indications.
Very pronounced age-related changes.
Deep wrinkles.
Post acne.
Hyperpigmentation.
XELA REDERM 2.2% is an injectable skin booster with a high concentration of hyaluronic acid and succinic acid, indicated for mature skin or skin with advanced signs of skin ageing. It is intended for those who wish to improve skin hydration, firmness and elasticity without creating artificial volume.
The treatment reduces the depth of wrinkles, improves skin tone and firmness, defines facial and lip contours and restores skin hydration, making the skin more even, radiant and toned.
It can be used on the face, cheeks, zygomatic area, neck, décolleté and hands, areas particularly prone to loss of tone, skin laxity or deeper wrinkles.
The treatment is performed with superficial or medium-superficial intradermal injections, following the papule technique. A cycle of 3-5 sessions is recommended, spaced 1-2 weeks apart, varying according to skin maturity. Results are visible progressively and improve with subsequent sessions.
There may be transient redness, oedema, mild pain or tension in the treated area. Exposure to intense heat, UV radiation, vigorous massage or strenuous physical activity should be avoided for the period indicated by your doctor. Any persistent reactions or unusual symptoms should be evaluated by a healthcare professional.